Shirazi thyme (Zataria multiflora) and ulcerative colitis

What 2 graded rows on shirazi thyme (zataria multiflora) agree on for ulcerative colitis, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Shirazi thyme (Zataria multiflora) page, with its PubMed record.

Your question

Supplement
Shirazi thyme (Zataria multiflora) Choose another

Shirazi thyme (Zataria multiflora) and ulcerative colitis

2 rows · 184 people

Split. 1 row found an improvement and 1 had mixed results.

Mixed
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Outlined: mixed results.
  • Grade C× 2
Rows
2
Trials
2
People
184

What the rows share

From the rows

The best-graded row, grade C, is a randomized trial of 92 people (2025) and found an improvement.

The rows run from 92 people, published in 2025: 2 single studies.

The rows

1 improved · 1 mixed
  1. Grade CColitis symptoms and antioxidant markers · Improved

    RCT · n 92 · 2025 · Adults with mild-to-moderate ulcerative colitis (multicentre, Iran)

    6 mg/kg/day · 2 months

    Bowel frequency, urgency of defecation, general well-being and final P-SCCAI scores improved vs placebo (all p < 0.001). TAC, SOD and thiol levels rose; malondialdehyde did not fall significantly (p = 0.06).

    Row on the Shirazi thyme (Zataria multiflora) page · PubMed 40319670 (opens PubMed)

  2. Grade CDisease activity, digestive symptoms and inflammation markers · Mixed

    RCT · n 92 · 2025 · Adults with ulcerative colitis (multicentre, Iran)

    6 mg/kg/day · 2 months

    GSRS digestive-symptom score improved (p < 0.001) and CRP, IL-17 and interferon-gamma fell, but the partial Mayo disease-activity score did not change significantly (p = 0.24), nor did ESR.

    Row on the Shirazi thyme (Zataria multiflora) page · PubMed 39987994 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.